Advertisement

Topics

CHMP OKs First EU Biosimilar Herceptin, And Another Version Of Humira

08:44 EDT 15 Sep 2017 | Elsevier Business Intelligence

Samsung Bioepis’s Ontruzant is set to be the first biosimilar version of Roche’s Herceptin on the EU market after getting...

Original Article: CHMP OKs First EU Biosimilar Herceptin, And Another Version Of Humira

NEXT ARTICLE

More From BioPortfolio on "CHMP OKs First EU Biosimilar Herceptin, And Another Version Of Humira"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...